See more : Ekter SA (EKTER.AT) Income Statement Analysis – Financial Results
Complete financial analysis of P3 Health Partners Inc. (PIII) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of P3 Health Partners Inc., a leading company in the Medical – Care Facilities industry within the Healthcare sector.
You may be interested
- Hybrid Software Group PLC (HYSG.BR) Income Statement Analysis – Financial Results
- Arsagera Asset Management (ARSA.ME) Income Statement Analysis – Financial Results
- Taiho Kogyo Co., Ltd. (6470.T) Income Statement Analysis – Financial Results
- PGT Innovations, Inc. (PGTI) Income Statement Analysis – Financial Results
- Belysse Group NV (BELYS.BR) Income Statement Analysis – Financial Results
P3 Health Partners Inc. (PIII)
About P3 Health Partners Inc.
P3 Health Partners Inc., a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. The company is based in Henderson, Nevada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 1.27B | 1.05B | 491.06B | 485.54M | 145.48M | 87.70M |
| Cost of Revenue | 1.23B | 1.14B | 668.07M | 485.30M | 141.03M | 0.00 |
| Gross Profit | 31.64M | -95.01M | 490.40B | 243.70K | 4.45M | 87.70M |
| Gross Profit Ratio | 2.50% | -9.05% | 99.86% | 0.05% | 3.06% | 100.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 122.36M | 157.30M | 53.39B | 53.39M | 36.42M | 28.54M |
| Selling & Marketing | 3.23M | 5.10M | 1.50B | 1.50M | 801.69K | 1.87M |
| SG&A | 125.60M | 162.40M | 54.89B | 54.89M | 37.23M | 30.41M |
| Other Expenses | 73.97M | 1.13B | 464.76B | 465.77M | 147.79M | -103.73K |
| Operating Expenses | 199.57M | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Cost & Expenses | 1.43B | 1.30B | 519.65B | 520.66M | 185.02M | 137.41M |
| Interest Income | 0.00 | 11.40M | 0.00 | 2.53M | 2.53M | 0.00 |
| Interest Expense | 15.99M | 11.40M | 10.68M | 2.53M | 2.53M | 0.00 |
| Depreciation & Amortization | 86.68M | 87.29M | 8.72M | 795.17K | 399.18K | 342.20K |
| EBITDA | -81.07M | -1.46B | -184.61M | -28.08M | -39.04M | -49.37M |
| EBITDA Ratio | -6.40% | -14.85% | -6.40% | -7.07% | -26.83% | -56.30% |
| Operating Income | -167.86M | -1.56B | -31.41B | -35.12M | -39.54M | -49.71M |
| Operating Income Ratio | -13.26% | -148.73% | -6.40% | -7.23% | -27.18% | -56.69% |
| Total Other Income/Expenses | -15.87M | 1.22M | -31.22B | -2.82M | -2.44M | -59.50K |
| Income Before Tax | -183.73M | -1.56B | -31.41B | -45.38M | -41.97M | -49.77M |
| Income Before Tax Ratio | -14.51% | -148.60% | -6.40% | -9.35% | -28.85% | -56.76% |
| Income Tax Expense | 2.70M | 1.90M | -31.40B | -4.00M | 2.63M | -6.02M |
| Net Income | -57.77M | -270.13M | -10.08M | -31.41M | -41.97M | -43.80M |
| Net Income Ratio | -4.56% | -25.74% | 0.00% | -6.47% | -28.85% | -49.95% |
| EPS | -0.61 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| EPS Diluted | -0.20 | -6.50 | -0.24 | -0.79 | -0.88 | -0.64 |
| Weighted Avg Shares Out | 94.89M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
| Weighted Avg Shares Out (Dil) | 294.59M | 41.58M | 41.58M | 39.53M | 47.59M | 68.16M |
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 29, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partn
NEW YORK, NY / ACCESSWIRE / August 28, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 27, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Investors of an Investigation into P3 Health Partn
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / August 26, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Informs Shareholders of an Investigation into P3 Health Par
NEW YORK, NY / ACCESSWIRE / August 22, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / August 21, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / August 20, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation into P3 Health Pa
NEW YORK, NY / ACCESSWIRE / August 19, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
SHAREHOLDER ALERT: Levi & Korsinsky, LLP Initiates Investigation into P3 Health Partners, Inc.
NEW YORK, NY / ACCESSWIRE / August 16, 2024 / The following statement is being issued by Levi & Korsinsky, LLP: To: All Persons or Entities who own P3 Health Partners, Inc. ("PII" or the "Company") (NASDAQ:PIII) stock purchased prior to December...
Source: https://incomestatements.info
Category: Stock Reports